B-MOGEN BIOTECHNOLOGIES

B-MoGen Biotechnologies Inc is a genome engineering startup located in Minneapolis, Minnesota. Founded in 2015, B-MoGen has entered strategic partnerships with biotechnology companies, completed projects for clients in academia and industry, and successfully licensed and developed novel intellectual property focused on genome engineering. B-MoGen Biotechnologies Inc offers custom tools for gene delivery and gene editing.
B-MOGEN BIOTECHNOLOGIES
Industry:
Biotechnology Genetics Health Care Medical Device
Founded:
2015-01-01
Address:
Saint Paul, Minnesota, United States
Country:
United States
Website Url:
http://www.bmogen.com
Total Employee:
1+
Status:
Active
Contact:
+116512087040
Email Addresses:
[email protected]
Total Funding:
1.03 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Official Site Inspections
http://www.bmogen.com
- Host name: 20.40.202.3
- IP address: 20.40.202.3
- Location: Des Moines United States
- Latitude: 41.6006
- Longitude: -93.6112
- Metro Code: 679
- Timezone: America/Chicago
- Postal: 50307

More informations about "B-MoGen Biotechnologies"
B-MoGen Biotechnologies - Crunchbase Company Profile & Funding
B-MoGen Biotechnologies Inc is a genome engineering startup located in Minneapolis, Minnesota. Founded in 2015, B-MoGen has entered strategic partnerships with biotechnology companies, โฆSee details»
B-MoGen Biotechnologies, Inc. | LinkedIn
B-MoGen Biotechnologies, Inc. | 993 followers on LinkedIn. Gene engineering providing proprietary, cutting-edge gene delivery enabling faster research and cost effective therapies | โฆSee details»
B-Mogen Biotechnologies, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for B-Mogen Biotechnologies, Inc. of Minneapolis, MN. Get the latest business insights from Dun & Bradstreet.See details»
B-MoGen Biotechnologies | St Paul, MN, US Startup - Gust
B-MoGen Biotechnologies is a Genome Engineering Company with novel Intellectual Property that has been spun out of the University of Minnesota.See details»
Bio-Techne Acquiring U of M Startup B-MoGen BioTechnologies
Jun 6, 2019 B-MoGen, founded in 2016, develops more complex gene editing tools for use in a wide variety of academic and industry settings. Being acquired by Bio-Techne will enable B โฆSee details»
Bio-Techne To Acquire B-MoGen Biotechnologies Inc. - Bio โฆ
614 McKinley Place NE Minneapolis, MN 55413 USA TEL 612 379 2956 Toll-free 800 343 7475 FAX 612 656 4400See details»
B-MoGen Biotechnologies - PitchBook
Jan 1, 2018 B-MoGen Biotechnologies General Information Description. Developer of genome engineering technology designed for gene delivery and gene editing. The company's technology offers custom vector generation โฆSee details»
B-MoGen Biotechnologies Inc - Company Profile and News
Company profile page for B-MoGen Biotechnologies Inc including stock price, company news, executives, board members, and contact informationSee details»
B-MoGen Biotechnologies - Products, Competitors, Financials, โฆ
Applied StemCell is a contract research, development, and manufacturing organization that focuses on gene editing and stem cell technologies within the biotechnology industry. The โฆSee details»
Press Releases - Bio-Techne Corporation
MINNEAPOLIS, Sept. 21, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that the B-MoGen Biotechnologies portfolio of genome engineering services, โฆSee details»
Bio-Techne Rebrands B-MoGen Biotechnologies As Part Of The โฆ
MINNEAPOLIS, Sept. 21, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that the B-MoGen Biotechnologies portfolio of genome engineering services, โฆSee details»
Bio-Techne To Acquire B-MoGen Biotechnologies Inc. - Novus โฆ
Jun 5, 2019 Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc. The transaction has โฆSee details»
B-MoGen Biotechnologies and CytoSen Therapeutics partner on โฆ
Jan 23, 2019 MINNEAPOLIS and DALLAS, Jan. 23, 2019 /PRNewswire/ -- B-MoGen Biotechnologies, Inc. and CytoSen Therapeutics announced today a research collaboration to โฆSee details»
Bio-Techne Acquiring U of M startup B-MoGen BioTechnologies
Jun 6, 2019 With a recent deal struck to buy B-MoGen Biotechnologies Inc., Minneapolis-based biotechnology manufacturer Bio-Techne has made its 15th acquisition within five years.See details»
B-MoGen Biotechnologies and CytoSen Therapeutics partner on โฆ
Jan 23, 2019 B-MoGen Biotechnologies, Inc. and CytoSen Therapeutics announced today a research collaboration to develop the next generation of gene-modified Natural Killer Cell (NK) โฆSee details»
Home | Bogen
The company has evolved since its founding in 1932, and the Bogen brand continues to focus on telephone paging systems, commercial audio, and sophisticated communications systems for โฆSee details»
Bio-Techne Rebrands B-MoGen Biotechnologies As Part Of The โฆ
Sep 21, 2020 --Bio-Techne Corporation today announced that the B-MoGen Biotechnologies portfolio of genome engineering services, GMP therapeutic manufacturing services, and its โฆSee details»
About BMO | BMO Financial Group - BMO Canada
At BMO, weโre trusted advisors, leaders in our communities and backers of opportunities that transform a continent. Letโs help you reach your financial goals.See details»
Sign in - BMO
Heads-up: you may not be able to access online and mobile banking right now because of a technical problem. We're working on the issue and will get things back to normal as soon as โฆSee details»
Nyquist System Controller Setup Guide - bogen.com
HTTP Provide access to Bogen product information. 80 HTTPS Secure HTTP 8089 HTTPS Secure HTTP (HTTP over TLS/SSL); used to provide access to Bogen product information. โฆSee details»